Vol 5 (2020): Continuous Publishing
Review paper
Published online: 2020-09-18

open access

Page views 713
Article views/downloads 1053
Get Citation

Connect on Social Media

Connect on Social Media

Diet and supplements as a supportive treatment for age-related macular degeneration

Jan Ostrowski1, Karolina Kątska-Ostrowska2, Wieslaw Gruszecki3, Robert Rejdak1
Ophthalmol J 2020;5:100-105.

Abstract

Age-related macular degeneration (AMD) is one of the leading causes of blindness in developed countries. It is estimated that about 196 million people worldwide suffer from AMD. So far, despite many studies, no causative treatment that can be used large scale has been discovered. In order to slow down, the progression of the disease, a change of the modifiable risk factors such as diet and prophylaxis in the form of nutritional supplements are recommended.

The purpose of this work is to present types of supplementation and draw attention to the proper diet containing products rich in substances such as lutein and zeaxanthin protecting the eye against the rapid progression of dry AMD.

Article available in PDF format

View PDF Download PDF file

References

  1. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995; 39(5): 367–374.
  2. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2): e106–e116.
  3. Nowak JZ. AMD — the retinal disease with an unprecised etiopathogenesis: in search of effective therapeutics. Acta Pol Pharm . 2014; 71(6): 900–916.
  4. Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond). 2016; 3: 34.
  5. Rinninella E, Mele MC, Merendino N, et al. The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis. Nutrients. 2018; 10(11).
  6. Datta S, Cano M, Ebrahimi K, et al. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017; 60: 201–218.
  7. Domènech EB, Marfany G. The Relevance of Oxidative Stress in the Pathogenesis and Therapy of Retinal Dystrophies. Antioxidants (Basel). 2020; 9(4).
  8. Heesterbeek TJ, Lorés-Motta L, Hoyng CB, et al. Risk factors for progression of age-related macular degeneration. Ophthalmic Physiol Opt. 2020; 40(2): 140–170.
  9. Shim SH, Kim SG, Bae JH, et al. Risk Factors for Progression of Early Age-Related Macular Degeneration in Koreans. Ophthalmic Epidemiol. 2016; 23(2): 80–87.
  10. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001; 119(10): 1417–1436.
  11. Gorusupudi A, Nelson K, Bernstein PS. The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration. Adv Nutr. 2017; 8(1): 40–53.
  12. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers. New Engl J Med. 1994; 330(15): 1029–1035.
  13. Johnson AR, Munoz A, Gottlieb JL, et al. High dose zinc increases hospital admissions due to genitourinary complications. J Urol. 2007; 177(2): 639–643.
  14. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013; 309(19): 2005–2015.
  15. Feng L, Nie K, Jiang H, et al. Effects of lutein supplementation in age-related macular degeneration. PLoS One. 2019; 14(12): e0227048.
  16. Bernstein PS, Li B, Vachali PP, et al. Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res. 2016; 50: 34–66.
  17. Ozawa Y, Shigeno Y, Nagai N, et al. Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration. BMC Ophthalmol. 2017; 17(1): 161.
  18. Loane E, Kelliher C, Beatty S, et al. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J Ophthalmol. 2008; 92(9): 1163–1168.
  19. Sabour-Pickett S, Nolan JM, Loughman J, et al. A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. Mol Nutr Food Res. 2012; 56(2): 270–286.
  20. Puell MC, Palomo-Alvarez C, Barrio AR, et al. Relationship between macular pigment and visual acuity in eyes with early age-related macular degeneration. Acta Ophthalmol. 2013; 91(4): e298–e303.
  21. Mukhtar S, Ambati BK. The value of nutritional supplements in treating Age-Related Macular Degeneration: a review of the literature. Int Ophthalmol. 2019; 39(12): 2975–2983.
  22. Aoki A, Inoue M, Nguyen E, et al. Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan. Sci Rep. 2016; 6: 20723.
  23. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol. 2006; 124(7): 995–1001.
  24. Borrelli E, Souied EH, Freund KB, et al. The role of omega-3 and micronutrients in age-related macular degeneration. Surv Ophthalmol. 2014; 59(5): 532–539.
  25. Georgiou T, Neokleous A, Nicolaou D, et al. Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids. PharmaNutrition. 2014; 2(1): 8–11.
  26. Lawrenson JG, Evans JR. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2012; 11: CD010015.
  27. Nashine S, Nesburn AB, Kuppermann BD, et al. Role of Resveratrol in Transmitochondrial AMD RPE Cells. Nutrients. 2020; 12(1).
  28. Lançon A, Frazzi R, Latruffe N. Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases. Molecules. 2016; 21(3): 304.
  29. Amirul Islam FM, Chong EW, Hodge AM, et al. Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study. Ophthalmology. 2014; 121(7): 1428–1434.e2.
  30. Chiu CJ, Chang ML, Zhang FF, et al. The relationship of major American dietary patterns to age-related macular degeneration. Am J Ophthalmol. 2014; 158(1): 118–127.e1.
  31. Merle B, Silver B, Rosner JM. Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Am J Clin Nutr. 2015; 102(5): 1196–1206.
  32. de Koning-Backus APM, Buitendijk GHS, Kiefte-de Jong JC, et al. Intake of Vegetables, Fruit, and Fish is Beneficial for Age-Related Macular Degeneration. Am J Ophthalmol. 2019; 198: 70–79.
  33. Chapman NA, Jacobs RJ, Braakhuis AJ. Role of diet and food intake in age-related macular degeneration: a systematic review. Clin Exp Ophthalmol. 2019; 47(1): 106–127.